AIDS-related cancers in Africa: Maturation of the epidemic in Uganda

AIDS

Volumn 13, Issue 18, 1999, Pages 2563-2570

  Parkin, D Maxwell ^a   Wabinga, Henry ^b   Nambooze, Sarah ^b   Wabwire Mangen, Fred ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

Africa; AIDS; Cancer; Cancer registries; Conjunctival neoplasms; Incidence; Kaposi's sarcoma; Non Hodgkin's lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CONJUNCTIVA TUMOR; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ONSET AGE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UGANDA; UTERINE CERVIX CANCER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS; REGISTRIES; SARCOMA, KAPOSI; SEX FACTORS; UGANDA;

EID: 0033375474     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199912240-00010     Document Type: Article

References (39)

1. 1. Serwadda D, Sewankambo NK, Carswell JW et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985, ii:849-852.
2. 2. Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr. 1998, 23:1-6.
3. 3. Biggar RJ, Horm J, Goedert JJ, Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987, 126: 578-586.
4. 4. Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of Acquired Immunodeficiency Syndrome. Int J Cancer 1989, 43:979-985.
5. 5. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1969-1977. Brit J Cancer 1999, (in press).
6. 6. Estève J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Volume IV. Descriptive Epidemiology. IARC Scientific Publications No. 128. 1994:302.
7. 7. Parkin DM, Pisani P, Muñoz N, Ferlay J. The global health burden of infection associated cancers. In: Cancer Surveys, Vol. 33: Infections and Human Cancer, 1998.
8. 8. WHO/UNAIDS, Epidemiological Fact Sheet on HIV/AIDS and Sexually Transmitted Diseases in Uganda 1998, http://www.who. int/emc/diseases/hiv.
9. 9. Taylor JF, Templeton AC, Vogel, CL, Ziegler JC, Kyalwazi, SK. Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer 1971, 8:122-135.
10. 10. Morgan D, Maude GH, Malamba SS et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997, 350:245-250.
11. 11. Beral V. Epidemiology of Kaposi's Sarcoma, In: Cancer, HIV and AIDS. Edited by Beral V, Jaffe HW, Weiss RA. Cancer Surveys Vol 10, Imperial Cancer Research Fund, Cold Spring Harbour Laboratory Press, 1990:5-22.
12. 12. Gao SJ, Kingsley L, Li M et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2:925-928.
13. 13. Simpson GR, Schulz TF, Whitby D et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-1138.
14. 14. Mayama S, Cuevas LE, Sheldon J et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998, 77:817-820.
15. 15. Ziegler JL, Katangole-Mbidde E. Kaposi's Sarcoma in Childhood: An analysis of 100 cases from Uganda and Relationship to HIV Infection. Int J Cancer 1996, 65:200-203.
16. 16. Bourboulia D, Whitby D, Boshoff C et al. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA 1998, 280:31-32.
17. 17. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers & Prev. 1999, 8, 97-106.
18. 18. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993, 41, 1-15.
19. 19. Goedert JJ, Cote TR, Virgo P et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998, 351:1833-1839.
20. 20. Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva (Review). Br J Cancer 1996, 74:1511-1513.
21. 21. Templeton AC. Tumours of the eye and adnexa. In Tumours in a Tropical Country. Recent Results in Cancer Research, Vol. 41. Ed. by Templeton, AC. Berlin, Heidelberg, New York: Springer Verlag; 1973, pp.203-214.
22. 22. Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 1995, 345: 695-696.
23. 23. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficieny virus epidemic . Int J Cancer 1991, 47:692-696.
24. 24. Newton R, Grulich A, Beral V et al. Cancer and HIV infection in Rwanda [letter]. Lancet 1995, 345:1378-1379.
25. 25. Sitas F, Bezwoda WR, Levin V, et al. Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 1997, 75:1704-1707.
26. 26. Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE: Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991, 265:2208-2211.
27. 27. Rabkin CS, Hilgartner MW, Hedberg KW, et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992, 267: 1090-1094.
28. 28. Lucas SB, Diomande M, Hounnou A, et al. HIV-associated lymphoma in Africa: an autopsy study in Cote d'lvoire. Int J Cancer 1994, 59: 20-24.
29. 29. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991, 337:805-809.
30. 30. Hamilton DS, Red D, Raphael M, et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993, 143:1072-1085.
31. 31. IARC monograph on the evaluation of carcinogenic risks to humans. Volume 70, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France: IARC; 1998.
32. 32. Whittle HC, Brown J, Marsh K, Blackman M, Jobe O, Shenton F. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 1990, 80:213-218.
33. 33. Pagano JS: Epstein-Barr virus: culprit or consort? N Engl J Med 1992, 327:1750-1752
34. 34. Melbye M, Cote TR, West D, Kessler L, Biggar RJ. Nasopharyngeal carcinoma: an EBV-associateda tumour not significantly influenced by HIV-induced immunosuppression. The AIDS/Cancer Working Group. Br J Cancer 1996, 73:995-997.
35. 35. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999, 13:839-843.
36. 36. Glaser SL, Lin RJ, Stewart SL et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997, 70:375-382.
37. 37. IARC monograph on the evaluation of carcinogenic risks to humans. Volume 67, Human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon, France: IARC, 1996.
38. 38. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994, 343:636-639.
39. 39. Chadwick EG, Connor EJ, Hanson IC et al. Tumors of smooth muscle origin in HIV-infected children. JAMA 1991, 263:3182-3184.